poisar

Stocks · News reference

B. Riley Securities Maintains Buy on Nutex Health, Raises Price Target to $325

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

NUTX
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Benzinga Newsdesk

    Nutex Health Reports Data Exfiltration And Faces Class-Action Lawsuit Following Cyberattack, Filed August 27, 2026 In U.S. District Court, Houston; Complaint Seeks Damages, Injunctive Relief, Credit Monitoring, Identity Theft Insurance, Attorneys' Fees; Says Unable To Predict Outcome Of Litigation Or Estimate Incident Impact At This Stage

    As disclosed in Item 8.01 of a Current Report on Form 8-K filed with the Securities and Exchange Commission on August 24, 2026 (the "Prior 8-K"), Nutex Health Inc. (the "Company") became aware of

    NUTX